Original Article| Volume 130, ISSUE 6, P700-707.e2, December 2020

Download started.


Eukaryotic translation elongation factor 1δ, N-terminal propeptide of type I collagen and cancer-associated fibroblasts are prognostic markers of oral squamous cell carcinoma patients

Published:October 29, 2020DOI:


      Identifying markers that influence oral squamous cell carcinoma (OSCC) prognosis is a fundamental strategy to improve the overall survival of patients. Markers such as eukaryotic translation elongation factor 1δ (EEF1D), fascin, N-terminal propeptide of type I collagen (PINP), and cancer-associated fibroblasts (CAFs) have been noticed in OSCCs and their levels are closely related to the prognosis of tumors. Our aim was to confirm the role of those markers in OSCC prognosis.

      Study Design

      Immunohistochemistry was performed in 90 OSCC specimens. The associations between clinicopathologic features and expression of markers were assessed by χ2 test. Kaplan-Meier curves and univariate and multivariate Cox regression models were used for survival analysis. Markers were analyzed individually and in combination.


      High expression of EEF1D (P = .017) and PINP (P = .02) and abundant density of CAFs in tumor stroma (P = .005) predicted significantly poor survival in OSCC patients. Multivariate analysis revealed that all 3 parameters are individually independent prognostic factors of OSCC patients, and their combination improved the discrimination of patients at high risk for poor survival.


      Our results suggested that the expression of EEF1D and PINP and the density of CAFs might influence the survival of patients with OSCC.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


        • Bray F.
        • Ferlay J.
        • Soerjomataram I.
        • Siegel R.L.
        • Torre L.A.
        • Jemal A.
        Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
        CA Cancer J Clin. 2018; 68: 394-424
        • Chi A.C.
        • Day T.A.
        • Neville B.W.
        Oral cavity and oropharyngeal squamous cell carcinoma—an update.
        CA Cancer J Clin. 2015; 65: 401-421
        • Lydiatt W.M.
        • Patel S.G.
        • O'Sullivan B.
        • et al.
        Head and Neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual.
        CA Cancer J Clin. 2017; 67: 122-137
        • Almangush A.
        • Makitie A.A.
        • Makinen L.K.
        • et al.
        Small oral tongue cancers (</= 4 cm in diameter) with clinically negative neck: from the seventh to the eighth edition of the American Joint Committee on Cancer.
        Virchows Arch. 2018; 473: 481-487
        • Tirelli G.
        • Gatto A.
        • Boscolo Nata F.
        • et al.
        Prognosis of oral cancer: a comparison of the staging systems given in the seventh and eighth editions of the American Joint Committee on Cancer Staging Manual.
        Br J Oral Maxillofac Surg. 2018; 56: 8-13
        • Flores I.L.
        • Kawahara R.
        • Miguel M.C.
        • et al.
        EEF1 D modulates proliferation and epithelial-mesenchymal transition in oral squamous cell carcinoma.
        Clin Sci (Lond). 2016; 130: 785-799
        • Rodrigues P.C.
        • Sawazaki-Calone I.
        • Ervolino de Oliveira C.
        • et al.
        Fascin promotes migration and invasion and is a prognostic marker for oral squamous cell carcinoma.
        Oncotarget. 2017; 8: 74736-74754
        • Bagordakis E.
        • Sawazaki-Calone I.
        • Macedo C.C.
        • et al.
        Secretome profiling of oral squamous cell carcinoma-associated fibroblasts reveals organization and disassembly of extracellular matrix and collagen metabolic process signatures.
        Tumour Biol. 2016; 37: 9045-9057
        • Dourado M.R.
        • Guerra E.N.S.
        • Salo T.
        • Lambert D.W.
        • Coletta R.D.
        Prognostic value of the immunohistochemical detection of cancer-associated fibroblasts in oral cancer: a systematic review and meta-analysis.
        J Oral Pathol Med. 2018; 47: 443-453
        • Hassan M.K.
        • Kumar D.
        • Naik M.
        • Dixit M.
        The expression profile and prognostic significance of eukaryotic translation elongation factors in different cancers.
        PLoS One. 2018; 13e0191377
        • De Bortoli M.
        • Castellino R.C.
        • Lu X.Y.
        • et al.
        Medulloblastoma outcome is adversely associated with overexpression of EEF1 D, RPL30, and RPS20 on the long arm of chromosome 8.
        BMC Cancer. 2006; 6: 223
        • Cheng D.D.
        • Li S.J.
        • Zhu B.
        • Zhou S.M.
        • Yang Q.C.
        EEF1 D overexpression promotes osteosarcoma cell proliferation by facilitating Akt-mTOR and Akt-bad signaling.
        J Exp Clin Cancer Res. 2018; 37: 50
        • Edwards R.A.
        • Bryan J.
        Fascins, a family of actin bundling proteins.
        Cell Motil Cytoskeleton. 1995; 32: 1-9
        • Kulasingam V.
        • Diamandis E.P.
        Fascin-1 is a novel biomarker of aggressiveness in some carcinomas.
        BMC Med. 2013; 11: 53
        • Alam H.
        • Bhate A.V.
        • Gangadaran P.
        • et al.
        Fascin overexpression promotes neoplastic progression in oral squamous cell carcinoma.
        BMC Cancer. 2012; 12: 32
        • Routray S.
        • Kheur S.
        • Chougule H.M.
        • Mohanty N.
        • Dash R.
        Establishing Fascin over-expression as a strategic regulator of neoplastic aggression and lymph node metastasis in oral squamous cell carcinoma tumor microenvironment.
        Ann Diagn Pathol. 2017; 30: 36-41
        • Lee M.K.
        • Park J.H.
        • Gi S.H.
        • Hwang Y.S.
        Proteases are modulated by fascin in oral cancer invasion.
        J Cancer Prev. 2018; 23: 141-146
        • Dourado M.R.
        • Miwa K.Y.M.
        • Hamada G.B.
        • et al.
        Prognostication for oral squamous cell carcinoma patients based on the tumour-stroma ratio and tumour budding.
        Histopathology. 2020; 76: 906-918
        • Kellermann M.G.
        • Sobral L.M.
        • da Silva S.D.
        • et al.
        Myofibroblasts in the stroma of oral squamous cell carcinoma are associated with poor prognosis.
        Histopathology. 2007; 51: 849-853
        • Cramer J.D.
        • Burtness B.
        • Le Q.T.
        • Ferris R.L.
        The changing therapeutic landscape of head and neck cancer.
        Nat Rev Clin Oncol. 2019; 16: 669-683
        • Almangush A.
        • Heikkinen I.
        • Makitie A.A.
        • et al.
        Prognostic biomarkers for oral tongue squamous cell carcinoma: a systematic review and meta-analysis.
        Br J Cancer. 2017; 117: 856-866
        • McLachlan F.
        • Sires A.M.
        • Abbott C.M.
        The role of translation elongation factor eEF1 subunits in neurodevelopmental disorders.
        Hum Mutat. 2019; 40: 131-141
        • Sasikumar A.N.
        • Perez W.B.
        • Kinzy T.G.
        The many roles of the eukaryotic elongation factor 1 complex.
        Wiley Interdiscip Rev RNA. 2012; 3: 543-555
        • Shuda M.
        • Kondoh N.
        • Tanaka K.
        • et al.
        Enhanced expression of translation factor mRNAs in hepatocellular carcinoma.
        Anticancer Res. 2000; 20: 2489-2494
        • Ogawa K.
        • Utsunomiya T.
        • Mimori K.
        • et al.
        Clinical significance of elongation factor-1 delta mRNA expression in oesophageal carcinoma.
        Br J Cancer. 2004; 91: 282-286
        • Liu Y.
        • Chen Q.
        • Zhang J.T.
        Tumor suppressor gene 14-3-3 sigma is down-regulated whereas the proto-oncogene translation elongation factor 1 delta is up-regulated in non-small cell lung cancers as identified by proteomic profiling.
        J Proteome Res. 2004; 3: 728-735
        • Pickup M.W.
        • Mouw J.K.
        • Weaver V.M.
        The extracellular matrix modulates the hallmarks of cancer.
        EMBO Rep. 2014; 15: 1243-1253
        • Nissen N.I.
        • Karsdal M.
        • Willumsen N.
        Collagens and Cancer associated fibroblasts in the reactive stroma and its relation to Cancer biology.
        J Exp Clin Cancer Res. 2019; 38: 115
        • Salo S.
        • Bitu C.
        • Merkku K.
        • et al.
        Human bone marrow mesenchymal stem cells induce collagen production and tongue cancer invasion.
        PLoS One. 2013; 8: e77692
        • Zou X.
        • Feng B.
        • Dong T.
        • et al.
        Up-regulation of type I collagen during tumorigenesis of colorectal cancer revealed by quantitative proteomic analysis.
        J Proteomics. 2013; 94: 473-485
        • Dean-Colomb W.
        • Hess K.R.
        • Young E.
        • et al.
        Elevated serum P1 NP predicts development of bone metastasis and survival in early-stage breast cancer.
        Breast Cancer Res Treat. 2013; 137: 631-636
        • Thurairaja R.
        • Iles R.K.
        • Jefferson K.
        • McFarlane J.P.
        • Persad R.A.
        Serum amino-terminal propeptide of type 1 procollagen (P1 NP) in prostate cancer: a potential predictor of bone metastases and prognosticator for disease progression and survival.
        Urol Int. 2006; 76: 67-71
        • Vallet S.
        • Hoyle N.R.
        • Kyle R.A.
        • Podar K.
        • Pecherstorfer M.
        A role for bone turnover markers beta-CrossLaps (CTX) and amino-terminal propeptide of type I collagen (PINP) as potential indicators for disease progression from MGUS to multiple myeloma.
        Leuk Lymphoma. 2018; 59: 2431-2438
        • Pimenta Amaral T.M.
        • Da Silva Freire A.R.
        • Carvalho A.L.
        • Pinto C.A.
        • Kowalski L.P.
        Predictive factors of occult metastasis and prognosis of clinical stages I and II squamous cell carcinoma of the tongue and floor of the mouth.
        Oral Oncol. 2004; 40: 780-786
        • Mellone M.
        • Hanley C.J.
        • Thirdborough S.
        • et al.
        Induction of fibroblast senescence generates a non-fibrogenic myofibroblast phenotype that differentially impacts on cancer prognosis.
        Aging (Albany NY). 2016; 9: 114-132
        • Ye H.
        • Yu T.
        • Temam S.
        • et al.
        Transcriptomic dissection of tongue squamous cell carcinoma.
        BMC Genomics. 2008; 9: 69
        • Kang C.J.
        • Chen Y.J.
        • Liao C.T.
        • et al.
        Transcriptome profiling and network pathway analysis of genes associated with invasive phenotype in oral cancer.
        Cancer Lett. 2009; 284: 131-140
        • Dourado M.R.
        • Korvala J.
        • Astrom P.
        • et al.
        Extracellular vesicles derived from cancer-associated fibroblasts induce the migration and invasion of oral squamous cell carcinoma.
        J Extracell Vesicles. 2019; 81578525
        • Kabir T.D.
        • Leigh R.J.
        • Tasena H.
        • et al.
        A miR-335/COX-2/PTEN axis regulates the secretory phenotype of senescent cancer-associated fibroblasts.
        Aging (Albany NY). 2016; 8: 1608-1635
        • Kelner N.
        • Rodrigues P.C.
        • Bufalino A.
        • et al.
        Activin A immunoexpression as predictor of occult lymph node metastasis and overall survival in oral tongue squamous cell carcinoma.
        Head Neck. 2015; 37: 479-486
        • Coletta R.D.
        • Salo T.
        Myofibroblasts in oral potentially malignant disorders: is it related to malignant transformation?.
        Oral Dis. 2018; 24: 84-88
        • Kellermann M.G.
        • Sobral L.M.
        • da Silva S.D.
        • et al.
        Mutual paracrine effects of oral squamous cell carcinoma cells and normal oral fibroblasts: induction of fibroblast to myofibroblast transdifferentiation and modulation of tumor cell proliferation.
        Oral Oncol. 2008; 44: 509-517
        • Lee T.K.
        • Poon R.T.
        • Man K.
        • et al.
        Fascin over-expression is associated with aggressiveness of oral squamous cell carcinoma.
        Cancer Lett. 2007; 254: 308-315